127 related articles for article (PubMed ID: 37403254)
21. Characterization of multidrug-resistant Acinetobacter baumannii strain ATCC BAA1605 using whole-genome sequencing.
Ten KE; Md Zoqratt MZH; Ayub Q; Tan HS
BMC Res Notes; 2021 Mar; 14(1):83. PubMed ID: 33663564
[TBL] [Abstract][Full Text] [Related]
22. Whole-Genome Analysis of
Guo T; Yang J; Sun X; Wang Y; Yang L; Kong G; Jiao H; Bao G; Li G
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080431
[TBL] [Abstract][Full Text] [Related]
23. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
24. Genomic and phenotypic analyses of multidrug-resistant
Kim M; Park J; Park W
Virulence; 2021 Dec; 12(1):150-164. PubMed ID: 33372826
[TBL] [Abstract][Full Text] [Related]
25. Complete genome sequence of the multidrug-resistant clinical isolate Acinetobacter baumannii KBN10P05679: Insights into antimicrobial resistance genotype and potential virulence traits.
Islam MM; Kim J; Kim K; Kim D; Akter S; Bang S; Kim S; Kim J; Lee JC; Shin M
J Glob Antimicrob Resist; 2023 Jun; 33():78-82. PubMed ID: 36889382
[TBL] [Abstract][Full Text] [Related]
26. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.
Trebosc V; Gartenmann S; Royet K; Manfredi P; Tötzl M; Schellhorn B; Pieren M; Tigges M; Lociuro S; Sennhenn PC; Gitzinger M; Bumann D; Kemmer C
Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072
[TBL] [Abstract][Full Text] [Related]
27. Unexplored Genetic Diversity of Multidrug- and Extremely Drug-Resistant
López-Leal G; Zuniga-Moya JC; Castro-Jaimes S; Graña-Miraglia L; Pérez-Oseguera Á; Reyes-García HS; Gough-Coto SD; Pavón-Madrid R; Bejarano SA; Ferrera A; Castillo-Ramírez S; Cevallos MA
Microb Drug Resist; 2019 Jun; 25(5):690-695. PubMed ID: 30614762
[TBL] [Abstract][Full Text] [Related]
28. Comparative genomics and characterization of a multidrug-resistant Acinetobacter baumannii VRL-M19 isolated from a crowded setting in India.
Verma N; Sharma T; Bhardwaj A; Vemuluri VR
Infect Genet Evol; 2024 Mar; 118():105549. PubMed ID: 38181886
[TBL] [Abstract][Full Text] [Related]
29. Genomic characterisation of a clinical Acinetobacter baumannii ST1928 isolate carrying a new ampC allelic variant bla
Jia H; Chen Y; Wang J; Ruan Z
J Glob Antimicrob Resist; 2019 Dec; 19():43-45. PubMed ID: 31449967
[TBL] [Abstract][Full Text] [Related]
30. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group.
Iacono M; Villa L; Fortini D; Bordoni R; Imperi F; Bonnal RJ; Sicheritz-Ponten T; De Bellis G; Visca P; Cassone A; Carattoli A
Antimicrob Agents Chemother; 2008 Jul; 52(7):2616-25. PubMed ID: 18411315
[TBL] [Abstract][Full Text] [Related]
31. A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development.
Galac MR; Snesrud E; Lebreton F; Stam J; Julius M; Ong AC; Maybank R; Jones AR; Kwak YI; Hinkle K; Waterman PE; Lesho EP; Bennett JW; Mc Gann P
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32718956
[TBL] [Abstract][Full Text] [Related]
32. Diversity of resistant determinants, virulence factors, and mobile genetic elements in
Kumkar SN; Kamble EE; Chavan NS; Dhotre DP; Pardesi KR
Front Cell Infect Microbiol; 2022; 12():997897. PubMed ID: 36519127
[TBL] [Abstract][Full Text] [Related]
33. Proteogenomic characterization of antimicrobial resistance in extensively drug-resistant Acinetobacter baumannii DU202.
Lee SY; Yun SH; Lee YG; Choi CW; Leem SH; Park EC; Kim GH; Lee JC; Kim SI
J Antimicrob Chemother; 2014 Jun; 69(6):1483-91. PubMed ID: 24486871
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Omega-3 Fatty Acids on the Evolution of Acinetobacter baumannii Drug Resistance.
Zang M; Adams FG; Hassan KA; Eijkelkamp BA
Microbiol Spectr; 2021 Dec; 9(3):e0145521. PubMed ID: 34762519
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
36. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.
Rumbo C; Gato E; López M; Ruiz de Alegría C; Fernández-Cuenca F; Martínez-Martínez L; Vila J; Pachón J; Cisneros JM; Rodríguez-Baño J; Pascual A; Bou G; Tomás M; ; ;
Antimicrob Agents Chemother; 2013 Nov; 57(11):5247-57. PubMed ID: 23939894
[TBL] [Abstract][Full Text] [Related]
37. Whole-genome analysis of an extensively drug-resistant clinical isolate of Acinetobacter baumannii AC12: insights into the mechanisms of resistance of an ST195 clone from Malaysia.
Lean SS; Yeo CC; Suhaili Z; Thong KL
Int J Antimicrob Agents; 2015 Feb; 45(2):178-82. PubMed ID: 25481460
[TBL] [Abstract][Full Text] [Related]
38. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance.
Lin MF; Lin YY; Tu CC; Lan CY
J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688
[TBL] [Abstract][Full Text] [Related]
39. Interspecies DNA acquisition by a naturally competent Acinetobacter baumannii strain.
Traglia GM; Place K; Dotto C; Fernandez JS; Montaña S; Bahiense CDS; Soler-Bistue A; Iriarte A; Perez F; Tolmasky ME; Bonomo RA; Melano RG; Ramírez MS
Int J Antimicrob Agents; 2019 Apr; 53(4):483-490. PubMed ID: 30611868
[TBL] [Abstract][Full Text] [Related]
40. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
